Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact surveillance

Sammy M. Njenga, Henry Kanyi, Collins Okoyo, Edward Githinji, Cassian Mwatele, Hadley S. Matendechero, Wyckliff P. Omondi, Patrick N. Gitahi, Chrispin Owaga, Joyce K. Onsongo, Katherine Gass
doi: https://doi.org/10.1101/2024.01.30.24301765

Article usage

Article usage: January 2024 to June 2025

AbstractFullPdf
Jan 202488012
Feb 2024712544
Mar 2024411617
Apr 2024241915
May 2024461115
Jun 2024291911
Jul 2024281817
Aug 202413155
Sep 20242645
Oct 202418128
Nov 20242436
Dec 20241886
Jan 20255088
Feb 2025323011
Mar 2025782314
Apr 20251073124
May 20251116320
Jun 20252923
Back to top
Posted January 30, 2024.
Download PDF
Data/Code
Email
Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact surveillance
Sammy M. Njenga, Henry Kanyi, Collins Okoyo, Edward Githinji, Cassian Mwatele, Hadley S. Matendechero, Wyckliff P. Omondi, Patrick N. Gitahi, Chrispin Owaga, Joyce K. Onsongo, Katherine Gass
medRxiv 2024.01.30.24301765; doi: https://doi.org/10.1101/2024.01.30.24301765
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area